SALT LAKE CITY, May 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative ... on Advanced Wound Care (SAWC) spring conference in San Antonio, TX.
News
- PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to ...
- Louisiana's unspent cash proposed for roads, colleges, coast
Other dollars would pay for LSU's Pennington Biomedical Research Center to recruit faculty. The LSU and Southern University AgCenters would get ...
- Moderna: 1Q Earnings Snapshot
The biotechnology company posted revenue of $16 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks ...
- Ocular Therapeutix: 1Q Earnings Snapshot
The biotechnology company posted revenue of $492,000 in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $446,000 ...
- PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to ...
SALT LAKE CITY, May 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue ... on Advanced Wound Care (SAWC) spring conference in San Antonio, TX.